The company aims to target cancer with new drugs that take advantage of protein degradation

Evox’ technology modifies exosomes to deliver drugs to areas currently inaccessible

The drug did not significantly improve overall survival or progression free survival in the first-line setting

Updated Date: Thu, 04 Jun 2020 00:00:00 EDT

Updated Date: Thu, 04 Jun 2020 00:00:00 EDT

Updated Date: Thu, 04 Jun 2020 00:00:00 EDT

Updated Date: Thu, 04 Jun 2020 00:00:00 EDT

Updated Date: Thu, 04 Jun 2020 00:00:00 EDT

AstraZeneca, Emergent BioSolutions sign $87M deal to produce U.S. supply of COVID-19 vaccine kblankenship Thu, 06/11/2020 – 14:49